Home Blog Page 2842

SKAI Bar & Grill Debuts Its Expanded Indoor Grill Sanctuary at Padma Resort Legian

BALI, Indonesia, Aug. 13, 2025 /PRNewswire/ — Building upon the undeniable popularity of its renowned beach–front mediterranean dining destination, Padma Hotels today unveils the expanded indoor extension of SKAI Bar & Grill at Padma Resort Legian. This new addition seamlessly continues the beloved seaside ambience into a lush garden–framed lounge, offering an intimate 34–seat setting for guests who crave the signature open–flame experience in a fresh, elevated atmosphere.

SKAI Bar & Grill - Padma Resort Legian
SKAI Bar & Grill – Padma Resort Legian

“Since opening our beach–front SKAI Bar & Grill, guests have fallen in love with the blend of ocean breezes, sunset views, and our fire–driven cuisine,” said Kristanti Tannady, General Manager, Padma Resort Legian. “With this extension, we’re honouring that spirit while creating a new stage for grill artistry, just steps away from the waves.”

A Natural Continuation of Coastal Charm

Just beyond the shoreline dining deck, the new terrace feels like a secret garden birthed from the original SKAI concept. Floor–to–ceiling windows complemented by verdant plantings and sculpted laser–cut screens that frame the golden hour in warm, dappled light. Hand–woven seating in driftwood grey and sandy taupe mirrors the beach’s natural palette, ensuring the extension remains a true kin to its waterfront origins.

Here, the Levantine–inspired creations flourish: imagine tender cuts anointed with fragrant za’atar, sumac–bright citrus glazes, and smoked–paprika pastes, each dish enhanced by the gentle sea breeze that drifts through planted alcoves and the soft glow of artisan lanterns overhead. This is seaside warmth, redefined through the spice and soul of the Eastern Mediterranean.

Why Mediterranean? A Culinary Story

SKAI’s concept was born from Padma’s desire to blend Bali’s rich local hospitality with the warm, convivial spirit of the Eastern Mediterranean. Imported ingredients—such as hand-harvested za’atar from Lebanon and Californian citrus preserved with Greek sea salt—anchor a menu that is now recognised as one of the most comprehensive Mediterranean offerings in Legian.

“We saw a clear guest appetite for bold spice blends, grilled meats, and shared-plate dining—hallmarks of Mediterranean culture,” adds Kristanti Tannady. “Our new indoor kitchen theatre showcases everything from dry-aged Angus Tenderloin to Ibérico Pork Chop Pata Negra, all paired with our famed wood-smoked sourdough.”

Grill Theater, Extended

At the heart of this expansion lies an open–kitchen pavilion; an exact mirror of the passion and precision found at the beach–front area. The chefs are artisans in motion, where every sizzle and pop becomes part of the evening’s performance, manipulating glowing embers and artisan charcoal with its primal beauty of fire and flavour, revealed in full, blending to deliver SKAI’s hallmark signature cuts: Angus Tenderloin, Grass–Fed MB3+ and Pork Chop Pata Negra Ibérico, among others. The dry–aging chamber is now showcased side by side on rustic maple boards, beckoning guests to explore even deeper layers of flavour in a fresh and elegant setting.

To personalise every bite, diners are invited to choose the expansive selection of salt, where a curated selection, from wood–smoked sea salt to herb–infused and zesty citrus blends, awaits their finishing flourish. And no grill experience is complete without our house–made sourdough, celebrated across Legian for its crackling crust and delightfully chewy crumb—the perfect companion for mopping up every last drop of jus.

Experience SKAI Bar and Grill Firsthand

From the first spark of ember to the final crumb of sourdough, every moment is designed to delight the senses. Secure your reservation today, and be among the first to witness the flame-driven journey into Mediterranean elegance.

For more information about Padma Hotels and to explore each property’s latest offerings, please visit PadmaHotels.com

About Padma Resort Legian

Padma Resort Legian is a five-star resort in Bali that comes under the banner of Padma Hotels management. It is encompassed within a 6.8 hectare parcel of tropical landscape overlooking Bali’s legendary sunset beach and is just 15 minutes from Ngurah Rai International Airport. The resort is an uplifting environment where guests can experience the fun of an artistic lifestyle. Accommodation is a collection of 432 comfortable rooms and suites, each with its own private balcony or terrace for heightened relaxation. Some exciting changes are currently in the making at Padma Resort Legian, stay tuned for further updates.

About Padma Hotels

Previously known as Sekar Alliance Hotel Management, Padma Hotels has two exclusive properties on the island of Bali, hillside town of Bandung and industrial area in Karawang. All of them are inspired by the rich artistry and cultural heritage of these unique locations. This is reflected through the design aesthetic as well as the gracious hospitality of each property. Padma Hotels is committed to the care and comfort of its guests through dedicated service and up-to-date facilities. Padma Resort Legian and Padma Resort Ubud are the perfect introduction to the carefree ambiance of tropical living, Padma Hotel Bandung uplifts the senses with breathtaking natural scenery while Resinda Hotel Karawang, managed by Padma Hotels is the new oasis in the center of industrial area.

Highly International Exhibitors, ITE HONG KONG 2026 covers GBA & Other Asia

HONG KONG, Aug. 13, 2025 /PRNewswire/ — Launched 40 years ago, ITE2026 incorporates the 40th ITE Leisure & 21st ITE MICE will be held from 11-14 June at halls 1 of Hong Kong Convention & Exhibition Centre, with two days for trade and two days for public. The annual ITE had also an early start on recovery with ITE2025 its 5th live edition since 2021.

Named MEGA EVENT, ITE2025 had 33% buyers & trade visitors from mainland China, and 20% from other Asia; 46% travel agents / operators, and 15% Corporate / MICE.

ITE 2025 Summary

Exhibitors

Buyers & Trade Visitors

Public Visitors

Countries & regions

502 (87.8%*)

7626 (53.2%*)

70212

64 (1/3 outside Asia)

*From Outside HK / Overseas

From China’s Greater Bay Area (GBA) came over 70% of ITE2025’s buyers & trade visitors who came individually or in official trade delegation from various cities. Also, hundreds of Guangdong residents registered for free admission in public days.

GBA, which includes Hong Kong (HK), Shenzhen and Guangzhou etc. in 2024 had a combined GDP of USD2077 billion, that makes it about world’s 12th largest economy.

In 2024, HK outbound fully recovered; ranked world’s 14th largest market by international tourism spending of US$28.9 billion, and say arrivals to Japan and Thailand respectively totaled 2.68 million and 0.88 million!

HK Outbound Spending / Departure

Year

Total Departures (million)

Int’l Tourism Expenditure^ (USD billion)

2024

104.7 (110.6%*)

$28.9 (107.4%*)

2023

72.2 (76.2%*)

$22.7 (84.4%*)

2019

94.7

$26.9

(*) Recovery Percentage against 2019  ^Source: UNWTO

Reflecting quality travelers, Trip.com reported HK residents doubled bookings to Paris for summer 2024 (Olympics); explore niche destinations and prefer quality lodging. Also, in first 5 months of 2025, HK made a total of 47.44 million departures, up 17.2%!

ITE2025 survey with 4242 replies found its many public visitors are premium and frequent travelers.  Well educated with 50% had university and 23% post-secondary; 90% keep or increase travel spending. By choice of destinations, SE Asia ranked third after mainland China and NE Asia with 19% been there in first half and 26% will visit in the second half this year.

ITE25 Survey on Travel Frequency

No of Outbound Holidays (2025)

Jan–Jun

Jul-Dec

3 or more

48.2 %

40.5 %

1 – 2

45.7 %

54.5 %

Zero

6.2 %

2.7 %

Business aplenty in ITE public days: 53% visitors interested in niche / new destinations, 43% plan book holiday onsite; 31% attend seminars; to save cash handling, many made onsite bookings and paid online by mobile!

Exhibitors can benefit from ITE’s separate B2B and B2C programs / services, which includes Buyers Meeting, KOL Networking, Speaking Opportunities to trade or public, pre & post show promotions to effectively reach out travel buyers and premium FIT under one roof.

Organized by TKS Exhibition Services Ltd., ITE is strongly supported by Ministry of Culture and Tourism of P.R. China, other supporters include Hong Kong Tourism Board etc.  Full article https://www.itehk.com/travelexpo/doc/press/ITE26_KickOff_15Jul25_en.pdf Expo’s website: www.itehk.com or inquiry via WhatsApp: +85294008444 Email: travel@tkshk.com

IBPO Announces Strategic Partnership with FWD Insurance to Provide Protection for Its Loan Financing Services

KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 13 August 2025 – IBPO Group Berhad (“IBPO”), a leading fintech company, has announced a strategic partnership with FWD Insurance Berhad (“FWD Insurance”), a leading Pan-Asian life insurer to safeguard its customers’ loans with life protection at a momentous Strategic Partnership Launch Ceremony held yesterday.

IBPO Group Berhad and FWD Insurance Berhad officially launches their Strategic Partnership to protect IBPO Customers’ loans with complimentary life insurance by FWD Insurance Berhad. From the middle left; IBPO Group Berhad, Founder & Group Managing Director, Andy Lim and the Chief Technology Officer, Samuel Quek. From the middle right, FWD Insurance Berhad, Chief Executive Officer, Mak See Sen and the Chief Digital, Direct & Telemarketing, Ann Lim.
IBPO Group Berhad and FWD Insurance Berhad officially launches their Strategic Partnership to protect IBPO Customers’ loans with complimentary life insurance by FWD Insurance Berhad. From the middle left; IBPO Group Berhad, Founder & Group Managing Director, Andy Lim and the Chief Technology Officer, Samuel Quek. From the middle right, FWD Insurance Berhad, Chief Executive Officer, Mak See Sen and the Chief Digital, Direct & Telemarketing, Ann Lim.

Officiated by Andy Lim, the Founder & Group Managing Director of IBPO and Mak See Sen, Chief Executive Officer of FWD Insurance, the signing ceremony was witnessed by Samuel Quek, Chief Technology Officer at IBPO and Ann Lim, Chief Digital, Direct & Telemarketing at FWD Insurance.

With this integrated partnership, selected IBPO’s loan financing facilities come with inclusive life protection, with no underwriting questions required. This will be applicable to IBPO’s Payday Financing and i-Bridge Financing programs, that are both launching this month.

What’s unique about these programs is that customers can now have peace of mind when applying for these programs, as the complimentary insurance coverage ensures that, in the event of unforeseen circumstances, their loved ones are protected from the burden of outstanding loan obligations.

Customers can easily apply for Payday Financing and i-Bridge Financing through IBPO’s online customer financial portal, myIBPO+, or via the upcoming all-in-one financial app. Both platforms are available 24/7 to help users manage and improve their finances.

Payday Financing is an interest-free advance cash for customers to cover urgent expenses before their monthly salary day. It’s fast, safe and 100% Shariah-compliant.

Meanwhile, i-Bridge Financing provides immediate short-term financing for homeowners, property sellers and SMEs to ease urgent cash flow gaps while awaiting disbursement of long-term bank financing, which typically takes up to 4 months. i-Bridge Financing is fully Shariah-compliant, in accordance with Islamic financing properties.

This initiative supports Bank Negara Malaysia’s Financial Sector Blueprint 2022–2026, which aims for greater digitalisation, inclusive financial access, and enhanced protection for households. By bridging fintech and insurance, IBPO and FWD Insurance are collectively supporting national goals to strengthen financial resilience, improve the financial well-being of Malaysians, and accelerate the adoption of secure, tech-driven financial solutions.

As part of this partnership, a total financing fund disbursement of RM100 million has been allocated exclusively for its customers, offering immediate financial assistance and for emergencies, business needs, property purchase and more, all backed by life insurance coverage for added security.

To provide greater convenience, customers can learn more about individual insurance plans with premiums starting from as low as RM8.10 per month, made available on the IBPO website starting this September 2025. These plans are designed to be more accessible and tailored to suit various lifestyles.

“We’re proud to partner with FWD Insurance, a customer-led brand that shares our commitment to improving financial literacy among Malaysians. This collaboration is key to empowering individuals to make smart, secure money moves that support both their immediate goals and long-term financial stability,” said Andy Lim, Founder & Group Managing Director of IBPO Group Berhad.

He added, “Our initiative with FWD Insurance allows customers to take on financing with maximum peace of mind and security in the event of an unfortunate incident, providing life coverage to our customers and to ease unexpected financial burden to their loved ones or if one faces any disability throughout the financing term – their loans are covered.”

“FWD Insurance is committed to changing the way people feel about insurance, by making it simpler, more accessible and truly meaningful. This partnership with IBPO is a powerful step forward in that vision. By embedding protection seamlessly into everyday financial solutions, we’re not just offering convenience, we’re delivering peace of mind. Through innovation and customer-first thinking, we’re helping Malaysians celebrate living, knowing their loved ones are protected no matter what life brings,” said Mak See Sen, CEO of FWD Insurance.

*Individual plan offer includes death, total and permanent disability (TPD), accidental death, hospitalisation benefits, critical illness, and a medical card, with protection up to RM500,000.

This initiative reinforces IBPO’s Fusion Finance model, a personalised, 360° innovative integrated approach with AI-powered technology and traditional finance solutions.

For more information, visit www.ibpo.com.my
*Subject to each individual policy’s terms and premium details.

Hashtag: #IBPOGroupBerhad #FWDInsuranceBerhad #LoanFinancingProtection

The issuer is solely responsible for the content of this announcement.

IBPO Group Berhad

is a fusion financial company that provides holistic personalised financial solutions to help clients achieve their financial aspirations and live a better life. Incorporated in 2012, IBPO Group became a public limited company in 2020.

We deliver bespoke financial consultancy services with our cutting-edge Fusion Financial System, a financial technology (“fintech”) system powered by Artificial Intelligence (“AI”) that was developed through extensive in-house IT research and development and ANIKA, the first AI-powered virtual financial consultant chatbot in Malaysia.

Our financial programs include; i-Refinancing, i-Connect, i-Console Plus, Payday Financing, i-Bridge Financing and Housing Value Investment. Discover personalised solutions tailored to your needs with mortgage refinancing, personal loans and financing, property management and more. To learn more, visit .

Follow Us: | | | | | @IBPO Group Berhad
Address: Level 28, Mercu Aspire, No. 3 Jalan Bangsar, KL Eco City 59200 Kuala Lumpur.
Email: contactus@ibpo.com.my
Head Office Contact No: +603 2201 2828

FWD Insurance Berhad

is part of FWD Group, a pan-Asian life and health insurance business that serves approximately 30 million* customers across 10 markets. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance and takaful. FWD Group is listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 1828. For more information, please visit .
FWD Insurance Berhad offers a variety of family and life insurance products, such as medical, critical illness, savings, and investment-linked plans. The company operates under the regulation of Bank Negara Malaysia in accordance with the Financial Services Act 2013.
For more information, please visit .

*including BRI Life in Indonesia.

SIBUR Develops New Polyethylene Grade for FMCG Packaging


MOSCOW, RUSSIA – Media OutReach Newswire – 13 August 2025 – SIBUR, Russia’s largest polymer producer, has developed a new grade of metallocene linear low-density polyethylene (mLLDPE) for flexible FMCG packaging.

The new grade – suitable for the production of barrier and lamination films, dairy packaging, as well as stretch films for wrapping – was developed by experts from SIBUR’s R&D centre with the direct involvement of several packaging manufacturers.

The grade, named mLL20183 FE, is comparable to foreign-made counterparts in terms of its physical and mechanical properties and has strong sales potential not only in Russia but also in international markets.

Products made from this polyethylene feature excellent sealing characteristics, strength, and tear resistance. Its improved processability enables film manufacturers to use blown film lines more efficiently. Additionally, the seamless transition between grades with different melt flow indices helps reduce operational costs.

Metallocene polyethylene is produced using metallocene catalysts (additives) based on zirconium or titanium, which enhance polymer properties, making it stronger, more transparent, and more flexible.

SIBUR produces metallocene polyethylene at the Nizhnekamskneftekhim production complex. By 2028, the company plans to fully modernise production by building a new plant capable of producing up to 300,000 tonnes of this premium polymer annually, which holds significant export potential.

Hashtag: #SIBUR

The issuer is solely responsible for the content of this announcement.

Wong To Yick Wood Lock Medicated Balm Proudly Announces Cantopop Diva Joey Yung as Its First-Ever Brand Ambassador

“No.1 Meets No.1” – A Legendary Collaboration Redefining Excellence

HONG KONG, Aug. 13, 2025 /PRNewswire/ — Renowned Hong Kong heritage brand Wong To Yick Wood Lock Medicated Balm today announced its groundbreaking partnership with Cantopop Diva Joey Yung as its first-ever brand ambassador. This landmark collaboration—“No.1 Meets No.1”—showcases Wong To Yick’s undisputed leadership as Hong Kong’s No.1 Muscle Pain Reliever¹ and No.1 in the Medicated Oil Segment², while leveraging Joey Yung’s global influence to elevate the brand’s legacy of professionalism and trust to new heights.

Wong To Yick Wood Lock Medicated Balm Proudly Announces Cantopop Diva Joey Yung as Its First-Ever Brand Ambassador
Wong To Yick Wood Lock Medicated Balm Proudly Announces Cantopop Diva Joey Yung as Its First-Ever Brand Ambassador

[High-resolution promotional photo download: Here]

A Legendary Union: Excellence Meets Excellence

The collaboration between Wong To Yick and Joey Yung is rooted in shared values of perseverance and excellence. Wong To Yick Wood Lock Medicated Balm has dominated Hong Kong’s pain relief market for over half a century, maintaining its position as the No.1 Muscle Pain Reliever[1] and No.1 in the Medicated Oil Segment[2] (by sales volume and value) for three consecutive years. Meanwhile, Joey Yung, renowned for her unparalleled dedication and resilience, embodies the brand’s spirit of “growing stronger through challenges.”

“ Wong To Yick Wood Lock Medicated Balm has been a trusted part of my life since childhood,” shared Joey Yung. “Whether it’s post-performance muscle fatigue or soreness from daily training, it delivers fast, effective relief. My personal experience aligns perfectly with the brand’s ethos of perseverance and strength.”

Wong To Yick & Joey Yung: Join Forces to Pioneer a New Brand Era

This landmark partnership between Wong To Yick Wood Lock Medicated Balm and Cantopop music icon Joey Yung marks a transformative milestone for this Hong Kong heritage brand with over half a century of history. As the brand’s first-ever ambassador, Joey Yung will leverage her widespread influence and positive public image to help redefine Wong To Yick’s identity—breaking free from traditional Chinese medicine stereotypes and cultivating a more youthful, fashionable brand appeal.

On the marketing front, Wong To Yick will launch a comprehensive promotional campaign, including high-end TV commercials that highlight the product’s efficacy alongside Joey’s star power, large-scale outdoor advertisements to amplify brand visibility, interactive social media initiatives to engage younger consumers, and strengthened retail partnerships to ensure optimal product availability and presentation. All marketing efforts will center on the theme “Perseverance, the Champion’s Choice,” seamlessly blending Joey Yung’s superstar persona with the brand’s professional credibility—reshaping modern consumers’ perception of premium Chinese herbal remedies.

Wong To Yick places consumer trust at the forefront, particularly in combating counterfeit products. The brand has established a robust anti-counterfeiting system and will roll out multi-tiered educational initiatives, including detailed authenticity guides on official websites and social platforms, empowering consumers to identify genuine products with ease. As the ambassador, Joey Yung shared, “As a Hong Kong native, I have unwavering faith in the words ‘Made in Hong Kong.’ Wong To Yick’s decades of consistent quality reflect not just a product commitment but the very essence of Hong Kong’s spirit. Every authentic bottle embodies this dedication and integrity.”

Since its founding in 1968 by Mr. Wong To Yick, the brand has remained steadfast in its Hong Kong manufacturing roots, using premium natural herbal ingredients to uphold the highest quality standards. Looking ahead, Wong To Yick will continue to embrace its “Growing Stronger Through Challenges” ethos, innovating while honoring tradition, to deliver superior health products to global consumers—ensuring this half-century legacy of craftsmanship endures for generations to come.

[1] Sales Value (HK$) and Sales Volume (KG/LITRE) in the Muscle Pain Reliever category from Feb 2022 – Jan 2025. (Copyright © 2025, NielsenIQ)
[2] Sales Value (HK$) and Sales Volume (KG/LITRE) in the Oil segment of Muscle Pain Reliever category from Feb 2022 – Jan 2025. (Copyright © 2025, NielsenIQ)

About Wong To Yick Wood Lock Medicated Balm

Wong To Yick Wood Lock Medicated Balm: A Hong Kong Legacy Spanning Over Half a Century

Brand Heritage

“Pain stems from blockage; relief comes from flow.” This ancient Chinese medical philosophy has been the lifelong guiding principle of Mr. Wong To Yick, founder of Wong To Yick Wood Lock Medicated Balm. As an iconic Hong Kong brand established in the 1960s and now in its second generation of leadership, Wong To Yick has remained steadfast in its original mission through decades of societal change, upholding the artisan spirit of “mastering one craft with relentless dedication.”

In 1968, Mr. Wong began his journey from a humble herbal tea shop in Sham Shui Po, combining decades of medical expertise with the essence of traditional Chinese medicine. Through rigorous clinical trials and formula refinement, he developed this revolutionary liniment with unparalleled penetrating efficacy. From grassroots word-of-mouth recognition to becoming an internationally renowned authority in Chinese herbal medicine, the product’s “activate circulation, relieve pain” benefits have made it a testament to Hong Kong’s excellence in traditional medicine.

Commitment to Craftsmanship

For over 50 years, Wong To Yick Wood Lock Medicated Balm has embodied the philosophy of “a lifetime devoted to perfecting one art.” Amidst changing times, the brand maintains 100% Made-in-Hong Kong integrity, with stringent quality control across every step of production at its self-operated factories in Kwai Chung and Yuen Long. From sourcing premium global herbal ingredients to blending time-honored techniques with modern technology, each bottle undergoes 18 meticulous processes to meet international pharmaceutical standards.

The Hong Kong Spirit & Brand Promise

To Wong To Yick, “Made in Hong Kong” is more than a label—it’s an enduring pledge. For over half a century, we’ve preserved traditional medicine craftsmanship with an artisan’s heart, ensuring every bottle upholds a solemn promise to consumer well-being.

The brand is built on three core values:

  • Efficacy: Time-tested formulas rooted in ancient wisdom
  • Safety: Naturally sourced herbs with rigorously monitored production
  • Trust: Uncompromising quality consistency for 50+ years

As brand ambassador Joey Yung reflects, “This isn’t just a liniment—it’s the crystallization of Hong Kong ingenuity.” From a Sham Shui Po shop to global markets, Wong To Yick epitomizes the true Hong Kong spirit: upholding professional essence through change while pursuing excellence through refinement. Every drop tells the story of Hong Kong’s “do one thing perfectly” perseverance.

This commitment has made Wong To Yick Wood Lock Medicated Balm a collective memory across three generations of Hong Kongers and an indispensable safeguard in countless household medicine cabinets. We believe genuine Hong Kong spirit isn’t measured by scale, but by an unyielding dedication to quality that stands the test of time.

For media inquiries, please contact:

Wong To Yick Wood Lock Oinment Limited.

Marketing & Sales Department
Tel: +852 2409 0920 | Email: info@wongtoyick.com.hk 

Official Channels:

Website: www.wongtoyick.com.hk
Facebook: https://www.facebook.com/Wongtoyick.com.hk
Instagram: https://www.instagram.com/wongtoyick/  

PR Agency:

SORTIE Agency Limited
Tel: +852 2855 6896 | Email: info@sortieagency.com 

KuCoin Partners with AlloyX to Explore RWA Token Collateral Mechanism Innovation, Enhancing User Asset Security and Liquidity

PROVIDENCIALES, Turks and Caicos Islands, Aug. 13, 2025 /PRNewswire/ — The globally leading cryptocurrency exchange KuCoin today announced a collaborative exploration with the digital financial infrastructure platform AlloyX to introduce Real-World Asset (RWA) tokens into the exchange’s collateral mechanisms. This partnership will pilot the integration of RWA token RYT, issued by a traditional licensed asset management company, into KuCoin’s Off-Exchange Settlement (OES) system for credit line management. The mechanisms will be gradually optimized and expanded based on market feedback.

This collaboration incorporates tokenized products from the “ChinaAMC USD Digital Money Market Fund,” issued by a traditional large-scale asset management institution—China Asset Management (Hong Kong) Limited—into the exchange’s credit system. It represents a new attempt to drive ongoing innovation in RWA application scenarios, further penetrating and establishing connections between Web2 and Web3 assets.

Crossover Initiative: Tokens Backed by Traditional Fund Assets Enter the Exchange Credit System

China Asset Management (Hong Kong) Limited is a wholly-owned subsidiary of China Asset Management Co., Ltd., and is one of the earliest Chinese asset management institutions in Hong Kong to conduct overseas business. It is the issuer of the underlying asset for the RYT token—the “ChinaAMC USD Digital Money Market Fund.” This fund is one of Asia’s first tokenized USD funds targeted at retail investors, with fund units available for subscription and redemption in token form.

Under this partnership mechanism, KuCoin will include RYT in its credit collateral list. Users holding the token can apply for credit lines in their platform accounts to support related trading operations. Backed by secure mechanisms and authentic assets, this innovative attempt provides a new use case for RWA tokens: users can earn underlying yields through holding, allowing investors to configure money market fund tokens as conveniently as other on-chain assets and increase asset allocation diversity, while also activating asset leverage value through collateralization.

Notably, the underlying asset structure of RYT has undergone rigorous compliance design, with functions such as fund custodian banking, fund administration, and unit registration handled by Standard Chartered Bank in Hong Kong, offering a trustworthy asset chain under a traditional financial framework.

KuCoin CEO BC Wong stated: “KuCoin has always been committed to bridging traditional finance and the crypto world through innovation. This collaboration with AlloyX to explore RWA tokens as collateral mechanisms exemplifies our dedication to providing users with secure and compliant solutions. We emphasize trustworthiness and risk control—this partnership not only elevates the platform’s innovation level but also delivers reliable asset appreciation opportunities to global users, helping them manage digital assets more confidently in dynamic markets.“

AlloyX Co-Founder and CEO Thomas Zhu remarked: “Our focus has always been on how RWA, as an asset form, can deliver more authentic and sustainable economic functions on-chain. This cooperation with KuCoin is a pragmatic attempt centered on ‘collateral mechanisms and scenario building,’ not only offering users more possibilities for asset utilization but also providing the industry with opportunities for structural validation.“

Long-Term Significance: Activating Liquidity and Guiding Market Consensus

Although RWA is still in its early development stage, its potential in institutional design, risk control, and asset-side construction is increasingly recognized by financial technology institutions. In this collaboration, AlloyX and KuCoin are linking up around RWA collateral mechanisms—not just a product-level integration test but potentially a vanguard for subsequent market standards and practical paths.

From an industry perspective, incorporating traditional asset tokens as compliant collateral into mainstream exchange credit systems is expected to enhance the depth of RWA usage and liquidity, while also providing observable models for more asset issuers, platform operators, and regulators.

In this context, KuCoin stated that it will continue to deepen exploratory collaborations with various parties to bring more innovative value to global users.

About KuCoin

Founded in 2017, KuCoin is a leading global cryptocurrency platform serving over 41 million users across 200+ countries and regions. Built on cutting-edge blockchain technology, KuCoin offers access to 1,000+ digital assets and solutions including Web3 wallet, Spot and Futures trading, institutional services, and payments. Recognized by Forbes as one of the “Best Crypto Apps & Exchanges” and a “Top 50 Global Unicorn” by Hurun, KuCoin is ISO 27001:2022 certified and committed to security, compliance, and innovation under the leadership of CEO BC Wong. Learn more: https://www.kucoin.com/

About AlloyX

AlloyX Limited is a technology company that specializes in global stablecoin payments and asset tokenization. Committed to integrating traditional banking payment systems with blockchain services, AlloyX provides secure and efficient stablecoin payment services and asset tokenization solutions. The company aims to become Asia’s leading stablecoin payments infrastructure and RWA tokenization technology provider. AlloyX offers embedded stablecoin wallet services and integrates various blockchain and payment solutions into its wallet and payment middle platform. The AlloyX platform also provides comprehensive solutions for stablecoin storage, payments, settlement, investment, foreign exchange, and asset tokenization, promoting the global adoption and application of stablecoin payments and tokenization technologies.

KBP’s Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration

SINGAPORE, Aug. 13, 2025 /PRNewswire/ — KBP Biosciences Pte. Ltd. (the “Company“) today issued a statement addressing a further decision by the Singapore International Commercial Court (the “Court“) to maintain the temporary injunction against the Company and its founder, Dr. Huang Zhenhua (“Dr. Huang“), in support of arbitration proceedings respectively commenced by the Company and by Novo Nordisk A/S (“Novo Nordisk“).

Following the Court’s judgment today, the validity of the injunction application sought by Novo Nordisk will be determined via the arbitral process, which the Company commenced before Novo Nordisk. More importantly, in the course of judgment, the Court examined a range of issues central to the dispute, including the conduct of clinical trials and the adequacy of due diligence. The findings of the Court are subject to further scrutiny by the arbitral tribunal, which will have more time and the benefit of hearing live testimony, unlike the Court.   

1.    Independent Testimony by Steering Committee Members

The judgment cites to the independent statements from steering committee members comprising Dr. Bertram Pitt and Dr. Janet Wittes, who are highly distinguished and well respected in the field. These evidence include an open letter by Dr. Pitt and Dr. Wittes on December 18, 2024, stating that “neither [Novo] nor KBP has provided any convincing evidence that the results from [the Bulgaria site] are fraudulent”. That open letter was unavailable to the Court in the previous ex parte hearing.

Further, if the Bulgaria site were indeed tainted by serious irregularities and fraud, the “FDA and EME would have responded. However, they have not responded, and Novo did not disclose this” in the previous ex parte hearing.

2.    Statistical Errors and the Futility Determination

Eight months after it acquired Ocedurenone, Novo Nordisk terminated the clinical trials for Ocedurenone because it thought they were futile. However, Parexel International (IRL) Ltd (“Parexel“) later “informed Novo that statistical errors had been made in compiling the data”. The judgment also states that:

“The defendants submit that Novo failed to disclose errors in the Futility Determination. After the Futility Determination was made, Parexel had informed Novo that statistical errors had been made in compiling the data. After correcting for the errors, Ocedurenone satisfied only one of two futility criteria (namely, it satisfied the SBP futility criteria but not the p-value futility criteria), such that the ‘anticipated hypothesis’ is that ‘treatment effect is significant but not substantial’, and Ocedurenone was still worth ‘continuing current development plans’ and not ‘worthless’ […]”.

3.    Failure to Disclose Information and Documents Provided

The judgment highlights that Novo Nordisk had access to “a full electronic data room with documents from KBP”, which would have allowed Novo Nordisk to conduct its own analysis. These documents included “data on the vital signs of every patient enrolled in Phase 2, identifying the site they were from as well as their [systolic blood pressure (“SBP“)]”. The judgment further states that:

“The defendants allege that Novo failed to disclose the material fact that during due diligence, KBP supplied Novo with raw data in the form of the Vital Signs Data Listing and the CTA Package. Novo did not open these documents, much less request a different format for the data.”

Every pharmaceutical company has a corporate social responsibility to care for patients and address unmet medical needs.

“KBP believes that Novo Nordisk erred in stopping the development of Ocedurenone because it could help patients. KBP intends to make this proof to the tribunal,” said Dr. Huang Zhenhua, founder and chairman of the Company. 

KBP has expended significant time and resources into the development of Ocedurenone, and it remains committed to its cause. As such, the Company and Dr. Huang will strive to engage the new management to find a way forward for Ocedurenone, whilst vigorously pursuing their rights in all legal proceedings commenced, including a possible appeal from the decision of the Singapore Court.

All media inquiries can be directed to: info@kbpbiosciences.com

About KBP Biosciences

KBP Biosciences is a global, clinical-stage biotechnology company, headquartered in Singapore, focused on discovering, developing, and commercializing innovative small-molecule therapeutics for the treatment of serious cardiorenal and infectious diseases with large unmet medical needs.

Second heartbeat

BEIJING, Aug. 13, 2025 /PRNewswire/ — A news report from chinadaily.com.cn

In this documentary, three patients suffered from advanced heart failure share their stories of how China’s independently-developed non-contact full maglev artificial heart brought hope to their lives. Click to learn more!